Dr. Foods, Inc.
DRFS · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.12 | 0.00 | 0.00 |
| FCF Yield | -20.24% | -9.83% | -0.00% | 0.00% |
| EV / EBITDA | -4.87 | -9.18 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | 2,699.13% | -64.65% | 14,958.69% | 1,843.20% |
| Gross Margin | 100.01% | 100.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.34 | 0.91 | 0.04 | 0.35 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 12.49% | -569.50% | -81.83% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 259.82 | 1,682.94 | 0.00 | 0.00 |